Table 1.
All(n = 646) | No CAD(n = 482) | CADa(n = 164) | p | |
---|---|---|---|---|
Age (years ± SD) | 62 ± 10 | 61 ± 9 | 66 ± 9 | <0.0001 |
Race (% white) | 82 | 83 | 79 | 0.11 |
Hypertension (%) | 62 | 60 | 68 | 0.14 |
Diabetes mellitus (%) | 26 | 23 | 37 | 0.0009 |
Current smoking (%) | 18 | 19 | 18 | 0.34 |
Lipid lowering Rx (%) | 33 | 26 | 51 | <0.0001 |
Current postmenopausal HT use (%) | 44 | 50 | 28 | 0.01 |
Education (%) | ||||
Less than high school | 22 | 20 | 30 | |
High school graduate | 40 | 39 | 42 | |
College | 38 | 41 | 28 | 0.01 |
Coronary Severity Score (±SD) | 15.8 ± 15.1 | 9.2 ± 5.8 | 35.6 ± 17.2 | <0.0001 |
Coronary disease was defined as ≥70% luminal diameter stenosis in more than one epicardial coronary artery.
All p-values are age-adjusted except age.
HT, hormone therapy; Rx, therapy; SD, standard deviation; “college” includes associate degree or vocational or training school after high school; CAD, coronary artery disease.